Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.

22.90 0.60 −2.55%
Market cap
$3.8B
P/E
38.8×
Fwd P/E
24.4×
Dividend yield
—
F-score
7/9
Altman Z
1.59
Beneish M
−2.50
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
7 3 3 4 8 4 — — — —
P/E ratio
77.54 0.00 0.00 22.79 21.25 168.65 18.44 5.52 5.52 5.52
Altman Z-Score
1.59 0.73 1.70 2.12 2.48 1.33 1.50 — — —
P/S ratio
1.34 1.32 1.57 2.15 2.90 2.79 1.77 0.00 0.00 0.00
P/FCF ratio
15.80 10.97 17.99 50.15 22.81 22.29 12.56 8.96 8.96 8.96
Altman Z″-Score (non-manufacturers)
2.63 0.79 3.10 2.73 2.86 1.25 2.04 — — —
P/Operating CF
33.77 25.09 39.43 50.15 53.41 27.84 21.59 29.37 29.37 29.37
Beneish M-Score
(2.50) (3.98) (2.74) (2.24) (2.40) (3.03) (3.35) — — —
P/B ratio
1.17 1.13 0.96 1.32 1.79 1.45 1.14 0.74 0.74 0.74
Price to Tangible BV
30.17 144.42 0.00 0.00 0.00 0.00 0.00 0.74 0.74 0.74
EV/Sales
1.47 1.45 1.79 2.45 2.99 3.26 2.25 0.00 0.00 0.00
EV/EBITDA
10.78 0.00 23.13 12.99 15.59 28.59 12.76 0.00 0.00 0.00
EV/Operating CF
14.51 10.84 16.67 34.52 20.76 22.15 12.96 6.97 6.97 6.97
EV/FCF
17.32 12.04 20.55 57.17 23.57 26.04 16.03 8.96 8.96 8.96
Quick Ratio
1.93 1.63 1.73 0.81 1.16 0.71 0.92 0.72 0.74 —
Current Ratio
2.38 2.04 2.23 1.15 1.52 0.94 1.41 1.23 1.27 —
Net Debt/EBITDA
0.64 (0.37) 2.89 1.59 0.50 4.12 2.76 0.00 0.00 0.00
Debt/Assets
25.50% 26.06% 22.91% 20.96% 20.01% 26.10% 21.51% 0.00% 0.00% —
Debt/Equity
0.47 0.48 0.36 0.33 0.32 0.48 0.37 0.00 0.00 —
Asset Turnover
0.49 0.42 0.39 0.39 0.37 0.30 0.38 0.97 0.48 0.00
Operating CF/Net income
5.87 (0.30) (2.75) 0.75 1.06 8.53 1.83 1.73 1.19 1.53
Capex/Depreciation
(0.29) (0.21) (0.31) (0.44) (0.25) (0.24) (0.45) (0.56) (0.40) 0.00
Interest Coverage
5.90 (22.37) 0.50 8.31 5.66 0.70 67.34 — — —
ROE
1.56% (31.47%) (2.39%) 5.88% 8.75% 0.92% 5.20% 4.70% 6.14% 0.00%
ROA
0.85% (18.71%) (1.52%) 3.69% 5.06% 0.51% 3.63% 7.90% 5.09% 0.00%
ROIC
4.04% (19.90%) 0.41% 4.01% 4.45% 0.59% 3.16% 3.86% 0.00% —
Return on Tangible Assets
3.20% (94.27%) (7.87%) 50.49% 38.19% 18.45% 37.32% 56.63% 75.65% 0.00%
Average Days of Receivables
57.66 52.77 57.95 55.91 48.29 57.08 70.87 59.00 60.12 0.00
Research and Development Expense of Revenue
4.19% 3.95% 3.65% 3.90% 4.01% 4.49% 5.83% 6.05% 6.13% 5.13%
Selling, General and Administrative Expense of Revenue
42.53% 46.12% 41.18% 41.08% 40.65% 47.93% 42.91% 39.78% 37.79% 37.09%
Intangible Assets out of Total Assets
0.53 0.54 0.64 0.70 0.64 0.63 0.75 0.81 0.00 —
Share Based Compensation of Revenue
1.38% 1.41% 1.20% 1.19% 1.12% 1.17% 0.81% 0.47% 0.44% 0.00%
Graham Net Nets
(0.15) (0.19) (0.17) (0.17) (0.09) (0.29) (0.40) 0.22 0.22 0.22
Graham Number
10.79 0.00 0.00 29.42 34.65 10.24 30.67 0.00 0.00 0.00
Earnings Yield
1.29% (33.64%) (2.28%) 4.39% 4.70% 0.59% 5.42% 18.10% 18.10% 18.10%
Free Cash Flow Yield
6.33% 9.12% 5.56% 1.99% 4.38% 4.49% 7.96% 11.16% 11.16% 11.16%
Revenue per Share
16.19 14.58 15.38 15.77 15.56 12.09 16.78 22.24 21.98 17.52
Operating CF per Share
1.64 1.95 1.65 1.12 2.24 1.78 2.92 3.13 2.81 2.62
Capex per Share
(0.27) (0.20) (0.31) (0.44) (0.27) (0.27) (0.56) (0.56) (0.38) 0.00
Free Cash Flow per Share
1.37 1.76 1.34 0.68 1.98 1.51 2.36 2.56 2.43 2.62
Cash per Share
7.21 6.21 5.63 3.73 6.66 5.57 1.55 0.00 0.00 0.00
Shareholders Equity per Share
18.49 17.04 25.01 25.83 25.17 23.31 26.01 37.74 0.00 0.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
18.49 17.04 25.01 25.83 25.17 23.31 26.01 37.74 0.00 0.00
Free Cash Flow
230.90 302.80 223.60 110.30 318.50 241.50 321.30 327.90 310.30 417.00
Working Capital
1,174.00 909.60 962.90 187.90 627.60 (94.10) 292.70 145.80 167.00 —
Capital Expenditures
(44.80) (33.70) (52.10) (72.40) (43.10) (42.40) (76.20) (72.20) (48.80) (49.10)
Net Current Asset Value
(546.10) (627.40) (687.50) (955.50) (680.40) (1,564.40) (1,613.60) (228.40) 795.00 —
EV/EBIT
18.51 0.00 145.89 19.76 24.51 144.57 21.85 0.00 0.00 0.00
Capex to Sales
0.02 0.01 0.02 0.03 0.02 0.02 0.03 0.03 0.02 0.00
Price to Operating Income
16.88 0.00 127.69 17.33 23.72 123.75 17.13 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.52 0.58 0.54 0.57 0.66 0.64 0.58 0.50 0.53 0.00
Cash ROIC
4.00% 5.61% 3.37% 1.78% 4.94% 3.77% 6.33% 6.79% 0.00% 0.00%
Accounts Receivable Turnover
6.86 6.52 6.41 7.08 7.92 5.18 5.06 6.16 6.09 0.00
Accounts Payable Turnover
6.73 6.43 5.52 5.29 5.58 4.26 4.40 5.66 10.03 9.88
Inventory Turnover
4.66 4.55 4.02 3.88 4.51 3.54 3.36 4.48 8.91 8.78
Average Days of Payables
56.73 56.01 58.19 76.15 62.65 84.54 81.15 63.85 68.11 4.76
Days of Inventory on Hand
85.30 77.30 83.89 100.33 88.96 90.18 108.42 81.86 84.68 (2.77)
Average Receivables
396.30 385.25 400.50 362.70 316.80 372.65 451.70 461.40 461.50 —
Average Payables
183.10 177.05 203.90 207.05 194.15 205.25 212.70 219.70 118.65 118.65
Average Inventory
264.55 249.90 279.80 282.30 239.90 246.95 278.30 277.35 133.55 133.55
Average Assets
5,514.75 5,977.80 6,596.05 6,580.60 6,725.10 6,517.15 5,999.95 2,920.80 5,917.50 —
Average Common Equity
3,020.55 3,554.35 4,190.40 4,132.45 3,889.50 3,631.90 4,184.60 4,908.70 4,907.00 —

Fold the line items

Columns are period end dates